13F-HR filed by Corriente Advisors, LLC
Corriente Advisors, LLC filed this 13F-HR for the quarter ended 2020-12-31, filed 2021-02-16, with 19 holding rows worth $420,091,000.
- Accession
- 0001085146-21-000992
- Filer
- CIK 1406718
- Filed
- 2021-02-16
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2020
A holdings report, 19 entries on the cover page, a total value of $420,091,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $420,091,000 with VALUE read as thousands by filing date, 13F file number 028-12875. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MAXAR TECHNOLOGIES INC | 57778K105 | COM | 2,500,000 | $96,475,000 | thousands by filing date | |
| REATA PHARMACEUTICALS INC | 75615P103 | CL A | 525,000 | $64,901,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 1,235,000 | $47,115,000 | thousands by filing date | |
| CARDIFF ONCOLOGY INC | 14147L108 | COM | 2,000,000 | $35,980,000 | thousands by filing date | |
| CAMECO CORP COM | 13321L108 | Stock | 2,177,086 | $29,173,000 | thousands by filing date | |
| GOPRO INC | 38268T103 | CL A | 3,350,000 | $27,738,000 | thousands by filing date | |
| CUE BIOPHARMA INC | 22978P106 | COM | 1,915,219 | $23,959,000 | thousands by filing date | |
| TFF PHARMACEUTICALS INC | 87241J104 | COM | 1,350,000 | $19,332,000 | thousands by filing date | |
| FIREEYE INC | 31816Q101 | COM | 690,000 | $15,911,000 | thousands by filing date | |
| APTOSE BIOSCIENCES INC COM | 03835T200 | Stock | 2,900,000 | $12,702,000 | thousands by filing date | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 190,000 | $9,052,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 1,100,000 | $9,009,000 | thousands by filing date | |
| CONCERT PHARMACEUTICALS INC | 206022105 | COM | 680,000 | $8,595,000 | thousands by filing date | |
| DIAMEDICA THERAPEUTICS INC | 25253X207 | COMMON STOCK | 806,900 | $8,182,000 | thousands by filing date | |
| KRATOS DEFENSE & SEC SOLUTIO | 50077B207 | COM NEW | 200,014 | $5,486,000 | thousands by filing date | |
| NEXGEN ENERGY LTD COM | 65340P106 | Stock | 1,000,000 | $2,758,000 | thousands by filing date | |
| ONCORUS INC | 68236R103 | COM | 78,043 | $2,523,000 | thousands by filing date | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 53,934 | $1,116,000 | thousands by filing date | |
| QUANTUMSCAPE CORP COM CL A | 74767V109 | Stock | 1,000 | $84,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001085146-21-000992 | this filing | 2021-02-16 | acceptance time not in the bulk data set |